688389.SS
Shenzhen Lifotronic Technology Co Ltd
Price:  
13.26 
CNY
Volume:  
3,458,853.00
China | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

688389.SS WACC - Weighted Average Cost of Capital

The WACC of Shenzhen Lifotronic Technology Co Ltd (688389.SS) is 11.1%.

The Cost of Equity of Shenzhen Lifotronic Technology Co Ltd (688389.SS) is 11.80%.
The Cost of Debt of Shenzhen Lifotronic Technology Co Ltd (688389.SS) is 5.00%.

Range Selected
Cost of equity 10.30% - 13.30% 11.80%
Tax rate 5.70% - 6.90% 6.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 9.7% - 12.5% 11.1%
WACC

688389.SS WACC calculation

Category Low High
Long-term bond rate 2.7% 3.2%
Equity market risk premium 6.1% 7.1%
Adjusted beta 1.24 1.35
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.30% 13.30%
Tax rate 5.70% 6.90%
Debt/Equity ratio 0.11 0.11
Cost of debt 5.00% 5.00%
After-tax WACC 9.7% 12.5%
Selected WACC 11.1%

688389.SS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 688389.SS:

cost_of_equity (11.80%) = risk_free_rate (2.95%) + equity_risk_premium (6.60%) * adjusted_beta (1.24) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.